Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma.

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Circulating cell-free nucleic acids are promising for non-invasive cancer diagnostics.
• Non-coding RNAs (ncRNAs) are implicated in tumor pathogenesis and show potential as cancer biomarkers.
• The utility of circulating long ncRNAs (c-lncRNAs) in osteosarcoma (OS) remains largely unexplored.

Purpose of the Study:

• To systematically review and identify c-lncRNAs associated with osteosarcoma.
• To explore the potential of these c-lncRNAs as diagnostic biomarkers for OS.
• To discuss the clinical implications of c-lncRNAs in OS management and precision oncology.

Main Methods:

• Systematic literature review to identify relevant studies.
• Analysis of circulating long non-coding RNAs (c-lncRNAs) expression in osteosarcoma patients.
• Evaluation of the association between c-lncRNA expression patterns and OS.

Main Results:

• Thirteen specific c-lncRNAs were identified with altered expression in the blood of OS patients.
• These c-lncRNAs demonstrate potential as novel biomarkers for osteosarcoma.
• The findings suggest distinct expression patterns linked to OS pathogenesis.

Conclusions:

• Circulating long non-coding RNAs represent a promising avenue for non-invasive osteosarcoma detection.
• The identified c-lncRNAs may contribute to improved clinical decision-making in OS management.
• This research provides insights for developing future precision medicine strategies in osteosarcoma oncology.